Biden Admin Announces Another $1 Billion for At-Home CCP Virus Tests

A used coronavirus disease (COVID-19) rapid test with negative result is pictured during pandemic lockdown, in Berlin, Germany, on March 31, 2021. Fabrizio Bensch/Reuters

The White House has announced plans to invest $1 billion into making rapid at-home tests for the Chinese Communist Party (CCP) Virus, which causes the disease COVID-19, widely available.

This comes days after the Food and Drug Administration (FDA) granted emergency use authorization for the ACON Laboratories Flowflex COVID-19 Home Test—a new rapid antigen test that can be purchased over-the-counter.